Files and links (1)
CC BY V4.0, Open Access
Journal article
Redox-active Vitamin C Suppresses Human Osteosarcoma Growth by Triggering Intracellular ROS-Iron-Calcium Signaling Crosstalk and Mitochondrial Dysfunction
Redox biology, Vol.75, 103288
09/2024
Abstract
Pharmacological vitamin C (VC) has gained attention for its pro-oxidant characteristics and selective ability to induce cancer cell death. However, defining its role in cancer has been challenging due to its complex redox properties. In this study, using a human osteosarcoma (OS) model, we show that the redox-active property of VC is critical for inducing non-apoptotic cancer cell death via intracellular reactive oxygen species (ROS)-iron-calcium crosstalk and mitochondrial dysfunction. In both 2D and 3D OS cell culture models, only the oxidizable form of VC demonstrated potent dose-dependent cytotoxicity, while non-oxidizable and oxidized VC derivatives had minimal effects. Live-cell imaging showed that only oxidizable VC caused a surge in cytotoxic ROS, dependent on iron rather than copper. Inhibitors of ferroptosis, a form of iron-dependent cell death, along with classical apoptosis inhibitors, were unable to completely counteract the cytotoxic effects induced by VC. Further pharmacological and genetic inhibition analyses showed that VC triggers calcium release through inositol 1,4,5-trisphosphate receptors (IP3Rs), leading to mitochondrial ROS production and eventual cell death. RNA sequencing revealed down-regulation of genes involved in the mitochondrial electron transport chain and oxidative phosphorylation upon pharmacological VC treatment. Consistently, high-dose VC reduced mitochondrial membrane potential, oxidative phosphorylation, and ATP levels, with ATP reconstitution rescuing VC-induced cytotoxicity. In vivo OS xenograft studies demonstrated reduced tumor growth with high-dose VC administration, concomitant with the altered expression of mitochondrial ATP synthase (MT-ATP). These findings emphasize VC's potential clinical utility in osteosarcoma treatment by inducing mitochondrial metabolic dysfunction through a vicious intracellular ROS-iron-calcium cycle.
Metrics
3 Record Views
Details
- Title
- Redox-active Vitamin C Suppresses Human Osteosarcoma Growth by Triggering Intracellular ROS-Iron-Calcium Signaling Crosstalk and Mitochondrial Dysfunction
- Creators
- Prajakta Vaishampayan - Department of Translational Medicine and Physiology, Elson S. Floyd College of Medicine, Washington State University, Spokane, WA 99202, USAYool Lee - Washington State University, Biomedical Sciences, Department of
- Publication Details
- Redox biology, Vol.75, 103288
- Academic Unit
- Sleep and Performance Research Center; Elson S. Floyd College of Medicine
- Publisher
- Elsevier B.V
- Identifiers
- 99901129225401842
- Language
- English
- Resource Type
- Journal article